ImClone Systems And Bristol-Myers Squibb Update The Status Of Non-Small Cell Lung Cancer Supplemental Biologics ... (Medical News Today) PDF Print

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (NYSE: LLY), and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the companies have decided, after discussion with the U.S.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.